WIDE Program Site Map: The Worldwide Initiative to Develop Everolimus

	Home
	Renal Cell Carcinoma - RCC
	Breast Cancer
	Lymphoma - MCL & DLBCL
	Tuberous Sclerosis Complex - TSC
	Hepatocellular Carcinoma - HCC
	Gastric Cancer
	About Novartis
	Tell a Colleague

Sitemap

» Home » Sitemap

Home – The WIDE Program (Worldwide Initiative to Develop Everolimus)

Renal Cell Carcinoma »	Tuberous Scerlosis »
RECORD 2	EXIST 2
RECORD 3
RAPTOR

Breast Cancer »	Hepatocellular »
BOLERO 1	EVOLVE 1
BOLERO 2
BOLERO 3

Lymphoma »	Gastric Cancer »
PILLAR 1	GRANITE 1
PILLAR 2

About Novartis	Tell a Colleague

Contact Us	Terms of Use
	Privacy Policy

Disclaimer : These are investigational studies; there is no guarantee that everolimus will become commercially available for these indications

Disclaimer : This is an international web site for the The WIDE Program™ providing general information for healthcare professionals from all countries. The information on this site is not country-specific and may contain information that is different from where you practice. Please contact your local Novartis Medical Scientific Liaison for the latest information specific to your country.
Home \| Renal Cell Carcinoma - RCC \| Breast Cancer \| Lymphoma - MCL & DLBCL \| Tuberous Sclerosis Complex - TSC Hepatocellular Carcinoma - HCC \| Gastric Cancer \| About Novartis \| Tell a Colleague
Contact Us \| Site Map \| Terms of Use \| Privacy Policy	© 2010 Novartis AG